← Leaderboards
Lloyd H Kasper
Dartmouth College
$9,400,939
Attributed
$9,400,939
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–15$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$9,400,939 · 10
By mechanism
R01$6,011,285 · 4
R42$2,264,726 · 1
R21$474,000 · 1
R41$322,928 · 1
R56$276,500 · 1
R03$31,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- Charles Robert Wira$14,448,906
Others in their field
Top investigators on “Immunoregulation”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Nevan J Krogan · University Of California, San Francisco$67,452,049
- James E. Gern · University Of Wisconsin-Madison$43,922,719
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- William W. Busse · University Of Wisconsin Madison$27,205,866
- Robert A Wood · Johns Hopkins University$25,022,095
Research focus
ImmunoregulationLeukocyte Activation /TransformationLaboratory MouseToxoplasma GondiiProtozoal AntigenTissue /Cell CultureT LymphocyteToxoplasmosisMicroorganism ImmunologyMultiple SclerosisHost Organism InteractionGut Associated Lymphoid TissueDendritic CellsPolymerase Chain ReactionCellular ImmunityDisease /Disorder Prevention /ControlAidsHelper T LymphocyteInterleukin 12Mucosal ImmunityBrain Imaging /Visualization /ScanningInflammatory Bowel DiseasesInhibitor /AntagonistAntigen Presentation
Grant awards (22)
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation$2,264,726
R42 · FY2015 · AI · contact PI
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation$322,928
R41 · FY2014 · AI · contact PI
GALT mediated protection against CNS demyelination: Role of commensal bacteria$276,500
R56 · FY2012 · AI · contact PI
T. Gondii: Antigenic Characterization and Immunity$385,718
R01 · FY2006 · AI · contact PI
T. Gondii: Antigenic Characterization and Immunity$395,000
R01 · FY2005 · AI
MULTIPLE-SCLEROSIS: A CD40 LIGAND ANTAGONIST$1
R01 · FY2005 · AI
T. Gondii: Antigenic Characterization and Immunity$390,360
R01 · FY2004 · AI
Commensal Bacteria in Regulation Of T gondii Induced IBD$237,000
R21 · FY2004 · AI
Conference on Translational Medicine in Autoimmunity$20,000
R13 · FY2004 · AI
MULTIPLE-SCLEROSIS: A CD40 LIGAND ANTAGONIST$1
R01 · FY2004 · AI
MULTIPLE-SCLEROSIS: A CD40 LIGAND ANTAGONIST$800,749
R01 · FY2003 · NS
T. Gondii: Antigenic Characterization and Immunity$379,340
R01 · FY2003 · AI
Commensal Bacteria in Regulation Of T gondii Induced IBD$237,000
R21 · FY2003 · AI
MULTIPLE-SCLEROSIS: A CD40 LIGAND ANTAGONIST$775,005
R01 · FY2002 · NS
T. Gondii: Antigenic Characterization and Immunity$383,783
R01 · FY2002 · AI
TOXOPLASMA GONDII--DIAGNOSIS AND PREVENTION IN AIDS$343,415
R01 · FY2002 · AI
MULTIPLE-SCLEROSIS: A CD40 LIGAND ANTAGONIST$774,510
R01 · FY2001 · NS
T GONDII--ANTIGENIC CHARACTERIZATION AND IMMUNOLOGY$364,503
R01 · FY2001 · AI
TOXOPLASMA GONDII--DIAGNOSIS AND PREVENTION IN AIDS$333,412
R01 · FY2001 · AI
T GONDII--ANTIGENIC CHARACTERIZATION AND IMMUNOLOGY$353,886
R01 · FY2000 · AI
TOXOPLASMA GONDII--DIAGNOSIS AND PREVENTION IN AIDS$331,602
R01 · FY2000 · AI
T GONDII--ROLE OF INTRAEPITHELIAL LYMPHOCYTE HOMING$31,500
R03 · FY2000 · TW